| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 270.00 |
Ecuador COVID-19 Emergency Response and Vaccination Project
Abstract*
The WBG Project will be comprised of two components to support the Government’s strategic plan to prevent and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness. In addition, climate change adaptation and mitigation measures will be incorporated throughout the sub-components, as applicable, and gender issues will be addressed as necessary. The specific activities financed by the Project fit into... Show More
Development Objective
To prevent and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness.
Key Details
Project Details
P173773
Closed
Laura Di Giorgio , Patricia Alvarez
Republic of Ecuador
March 24, 2020
(as of board presentation)
April 2, 2020
April 5, 2020
US$ 20.00 million
Ministry of Public Health
2020
US$ 270.00 million
N/A
Moderate
March 30, 2024
No
BANK APPROVED
June 14, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 270.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 270.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 20.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Mar 15, 2021 | IBRD-90870 | Loan Disb | 7,329,288.00 |
| Dec 14, 2020 | IBRD-90870 | Loan Disb | 7,329,288.00 |
| Mar 15, 2021 | IBRD-90870 | Int Charges | 34,830.40 |
| Mar 15, 2021 | IBRD-90870 | Int Charges | 140,312.16 |
| Sep 15, 2020 | IBRD-90870 | Loan Disb | -10,094,400.00 |
| Sep 15, 2020 | IBRD-90870 | Loan Disb | 10,094,400.00 |
| Jan 1, 2024 | IBRD-94330 | Int Charges | 28,026.68 |
| Jan 1, 2024 | IBRD-94330 | Int Charges | 684.94 |
| Oct 24, 2023 | IBRD-94330 | Loan Disb | 6,860,976.50 |
| Jun 26, 2023 | IBRD-94330 | Loan Disb | 29,767,246.00 |
| Sep 15, 2023 | IBRD-92280 | Int Charges | 56,199.30 |
| Sep 15, 2023 | IBRD-92280 | Int Charges | 3,601.06 |
| Sep 15, 2023 | IBRD-92280 | Int Charges | 4,332,132.00 |
| Mar 15, 2022 | IBRD-90870 | Int Charges | 136,324.77 |
| Sep 16, 2021 | IBRD-92280 | Loan Disb | 12,099,960.00 |
| Sep 15, 2021 | IBRD-90870 | Int Charges | 1,817.53 |
| Sep 15, 2021 | IBRD-90870 | Int Charges | 140,312.16 |
| Sep 15, 2021 | IBRD-90870 | Int Charges | 136,324.77 |
| Sep 15, 2021 | IBRD-92280 | Int Charges | 152,370.27 |
| Sep 16, 2021 | IBRD-92280 | Loan Disb | 8,066,640.00 |
| Sep 7, 2021 | IBRD-92280 | Loan Disb | 19,200,000.00 |
| Aug 23, 2021 | IBRD-92280 | Loan Disb | 28,800,000.00 |
| May 24, 2021 | IBRD-92280 | Loan Disb | 48,116,924.00 |
| May 20, 2021 | IBRD-92280 | Fee Charges | 375,000.00 |
| Mar 15, 2021 | IBRD-90870 | Loan Disb | -7,329,288.00 |
| Sep 15, 2020 | IBRD-90870 | Int Charges | 119,175.61 |
| Apr 7, 2020 | IBRD-90870 | Fee Charges | 50,000.00 |
| Apr 10, 2020 | IBRD-90870 | Loan Disb | 10,094,400.00 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | -814,496.40 |
| Jul 2, 2023 | IBRD-94330 | Loan Disb | -14,746,152.00 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | -4,594.19 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | -24,863.38 |
| Jul 2, 2023 | IBRD-94330 | Loan Disb | -14,746,152.00 |
| Jul 2, 2023 | IBRD-94330 | Loan Disb | 14,746,152.00 |
| Apr 1, 2021 | IBRD-92280 | Loan Commitment | 150,000,000.00 |
| Apr 2, 2020 | IBRD-90870 | Loan Commitment | 20,000,000.00 |
| Jun 27, 2022 | IBRD-94330 | Loan Commitment | 100,000,000.00 |
| Jul 2, 2023 | IBRD-94330 | Loan Disb | 14,746,152.00 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | -1,039,560.94 |
| Mar 15, 2024 | IBRD-92280 | Int Charges | 75,495.20 |
| Mar 15, 2024 | IBRD-90870 | Int Charges | 140,312.16 |
| Mar 15, 2024 | IBRD-90870 | Int Charges | 136,324.77 |
| Mar 15, 2024 | IBRD-90870 | Int Charges | 3,208.02 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | 4,594.19 |
| Jan 1, 2024 | IBRD-94330 | Loan Disb | 35,486,604.00 |
| Jan 1, 2024 | IBRD-94330 | Loan Disb | -35,486,604.00 |
| Mar 15, 2024 | IBRD-92280 | Int Charges | 4,806,293.50 |
| Mar 15, 2024 | IBRD-92280 | Int Charges | 3,557.96 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | 24,863.38 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | 1,039,560.94 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | 814,496.40 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | 4,594.19 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | 1,039,560.94 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | 814,496.40 |
| Jul 1, 2024 | IBRD-94330 | Int Charges | 24,863.38 |
| Jan 1, 2024 | IBRD-94330 | Int Charges | 735,581.44 |
| Jan 1, 2024 | IBRD-94330 | Int Charges | 1,053,384.80 |
| Jun 29, 2023 | IBRD-94330 | Loan Disb | 14,746,152.00 |
| Sep 5, 2023 | IBRD-94330 | Loan Disb | 4,144,665.20 |
| Jul 1, 2023 | IBRD-94330 | Loan Disb | -44,513,396.00 |
| Jul 1, 2023 | IBRD-94330 | Loan Disb | 44,513,396.00 |
| Sep 15, 2023 | IBRD-90870 | Int Charges | 3,246.86 |
| Sep 15, 2023 | IBRD-90870 | Int Charges | 140,312.16 |
| Sep 15, 2023 | IBRD-90870 | Int Charges | 136,324.77 |
| Aug 21, 2023 | IBRD-94330 | Loan Disb | 24,480,962.00 |
| Mar 15, 2023 | IBRD-92280 | Int Charges | 3,229.21 |
| Mar 15, 2023 | IBRD-92280 | Int Charges | 3,749,379.00 |
| Sep 15, 2022 | IBRD-92280 | Int Charges | 2,415.19 |
| Sep 15, 2022 | IBRD-90870 | Int Charges | 140,312.16 |
| Sep 15, 2022 | IBRD-90870 | Int Charges | 136,324.77 |
| May 2, 2023 | IBRD-94330 | Fee Charges | 250,000.00 |
| Mar 15, 2023 | IBRD-90870 | Int Charges | 3,193.93 |
| Mar 15, 2023 | IBRD-90870 | Int Charges | 140,312.16 |
| Mar 15, 2023 | IBRD-90870 | Int Charges | 136,324.77 |
| Mar 15, 2023 | IBRD-92280 | Int Charges | 167,612.77 |
| Sep 15, 2022 | IBRD-90870 | Int Charges | 3,246.86 |
| Sep 15, 2022 | IBRD-92280 | Int Charges | 1,412,477.90 |
| Sep 6, 2022 | IBRD-92280 | Loan Disb | 629,686.25 |
| Feb 28, 2022 | IBRD-92280 | Loan Disb | 6,232,729.50 |
| Dec 27, 2021 | IBRD-92280 | Loan Disb | 14,418,300.00 |
| Dec 27, 2021 | IBRD-92280 | Loan Disb | 9,578,400.00 |
| Mar 15, 2022 | IBRD-92280 | Int Charges | 22,666.67 |
| Mar 15, 2022 | IBRD-92280 | Int Charges | 591,554.75 |
| Mar 15, 2022 | IBRD-90870 | Int Charges | 3,193.93 |
| Mar 15, 2022 | IBRD-90870 | Int Charges | 140,312.16 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2024-06-28 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-06-28 |
| Project Management | Moderately Satisfactory | 2024-06-28 |
| Financial Management | Moderately Satisfactory | 2024-06-28 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-06-28 |
| Procurement | Moderately Satisfactory | 2024-06-28 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of referrals to secondary and tertiary hospitals financed by the project during the COVID-19 emergency, disaggregated by sex Value 0.00 52751.00 5000.00 Date May 9, 2022 March 29, 2024 March 29, 2024 Comment Number of health workers reached with tailored information Value 0.00 325787.00 10000.00 Date April 1, 2020 March 29, 2024 March 31, 2024 Comment Percentage of prioritized ICU units that are fully equipped and operational Value 0.00 37.22 30.00 Date April 1, 2020 March 29, 2024 June 30, 2022 Comment Percentage of diagnosed cases that need hospitalization per approved protocol treated in the prioritized hospitals, disaggregated by sex Value 0.00 6.67 10.00 Date April 1, 2020 March 29, 2024 June 30, 2022 Comment Percentage of population vaccinated, which is included in the priority population targets defined in the national plan, disaggregated by sex Value 0.00 82.77 60.00 Date February 10, 2021 March 29, 2024 March 29, 2024 Comment Percentage of population vaccinated, which is included in the priority population targets, females Value 0.00 87.68 30.00 Date February 10, 2021 March 29, 2024 March 29, 2024 Comment Percentage of population vaccinated, which is included in the priority population targets, males Value 0.00 86.48 30.00 Date February 10, 2021 March 29, 2024 March 31, 2024 Comment Number of referrals to hospitals financed by the project during the COVID-19 emergency, females Value 0.00 26560.00 2500.00 Date May 9, 2022 April 19, 2024 March 29, 2024 Comment Number of referrals to hospitals financed by the project during the COVID-19 emergency, males Value 0.00 26191.00 2500.00 Date May 9, 2022 April 19, 2024 March 29, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of public health campaign audiovisual materials disseminated Value 0.00 61.00 50.00 Date April 1, 2020 June 15, 2024 March 29, 2024 Comment Number of public health messages disseminated through Internet based mediums Value 0.00 146.00 100.00 Date April 1, 2020 June 15, 2024 March 29, 2024 Comment Percentage of ICU beds in prioritized ICU units that are fully equipped and operational Value 0.00 43.30 30.00 Date April 1, 2020 June 15, 2024 June 30, 2022 Comment Percentage of prioritized ICU units that are fully equipped with shared equipment Value 0.00 37.22 30.00 Date April 1, 2020 June 15, 2024 June 30, 2022 Comment Number of cold chain equipment (refrigerator and freezers) installed by the project Value 0.00 0.00 30.00 Date February 10, 2021 June 15, 2024 March 29, 2024 Comment Number of vaccine doses procured Value 0.00 18041215.00 10000000.00 Date April 1, 2020 June 15, 2024 March 29, 2024 Comment Number of actions taken in vaccine deployment and distribution based on feedback from beneficiaries Value 0.00 7.00 10.00 Date February 10, 2021 June 15, 2024 March 29, 2024 Comment Percentage of vaccine recipients satisfied with their experience Value 0.00 0.00 66.00 Date February 10, 2021 June 15, 2024 March 29, 2024 Comment The vaccine eligibility criteria includes temporary/informal health workers Value No Yes Yes Date March 5, 2021 June 15, 2024 December 30, 2021 Comment The communications campaigns developed and disseminated materials aimed to increase the vaccination rate of women Value No Yes Yes Date March 5, 2021 June 15, 2024 December 31, 2021 Comment Percentage of women reached with communication campaign with messages around vaccination Value 0.00 95.13 40.00 Date March 5, 2021 June 15, 2024 March 29, 2024 Comment Number of patients who received dialysis sessions financed by the Project during the COVID-19 emergency, disaggregated by sex Value 0.00 4396.00 2000.00 Date May 9, 2022 June 15, 2024 March 29, 2024 Comment